Harrison Ford and Michael J. Fox Spotlight Parkinson’s Therapy

Last January, Michael J. Fox was awarded the Presidential Medal of Freedom by then-President Joe Biden, honoring his dedication to Parkinson’s research and awareness. Diagnosed with Parkinson’s disease in 1991, Fox has since become a prominent advocate, channeling efforts through the Michael J. Fox Foundation, which has invested over $2.5 billion in research over 25 years, including raising more than $100 million annually.

Fox emphasized the foundation’s significant role in funding Parkinson’s research, stating,

“Our foundation directs more money towards Parkinson’s research than the federal government,”

to Vanity Fair. Reflecting on engagement with the Trump administration, Fox remarked,

“He’s busy with Greenland. More pressing concerns, I guess.”

Efforts to Engage Government on Brain Research

Fox announced plans to meet soon with Robert F. Kennedy Jr., head of the US Department of Health and Human Services, aiming to discuss federal strategies on brain disease research. He explained to reporters,

“I’m going to Washington next month and hopefully talk to Kennedy and find out what the government’s game plan is on addressing brain research in general and taking a more serious approach to some of these things that are soluble,”

emphasizing the need for a focused governmental response.

Fox elaborated on the complexities of Parkinson’s, describing it as,

“just a weird disease. We always say genetics loads a gun and environment pulls the trigger. We’re trying to figure out what’s biological and what’s chemical.”

Depicting Parkinson’s in ‘Shrinking’ and Collaboration with Harrison Ford

The recently premiered third season of the series Shrinking, airing January 28, explores Parkinson’s through the character arc of Jerry, portrayed by Fox, who navigates his diagnosis alongside therapist Paul, played by Harrison Ford. Ford interjected during a conversation about the show, acknowledging Fox’s commitment:

“Michael raises more money for and has done more Parkinson’s research than almost anybody in the world.”

To which Fox responded,

“It’s a credit to our great people,”

while expressing frustration over limited government involvement:

“It’s frustrating to know we’re putting everything we can into it, and it would be nice to have the government behind us, but it seems that they’re involved in other things that have less impact on peoples’ lives.”

Historical Connection and Advocacy for Stem Cell Research

Fox and Ford first appeared together publicly in 2004 at a charity event calling for stem cell research, with then-First Lady Nancy Reagan prominently supporting the cause. Fox recalled the moment fondly, saying,

“I’m sure I was very excited to see Harrison, And Nancy Reagan—she was a force.”

Reagan’s support stood out, especially among conservatives, as she openly endorsed embryonic stem cell research, which has continued to face opposition in Congress. Fox has consistently advocated for this research path, viewing it as critical to finding Parkinson’s treatments. He noted the importance of Reagan’s stance:

“For someone like Mrs. Reagan to step outside of political or ideological groupings and just speak to what she believes…is tremendously valuable,”

from remarks made at the 2004 event.

Returning to Television with Bill Lawrence and Friendship Reunited

After earlier roles in Family Ties and Spin City, Fox reunited with creator Bill Lawrence for Shrinking. The show earned Harrison Ford his first Emmy nomination last year, highlighting their joint efforts on a meaningful project. Fox recounted his reaction upon being approached about the show:

“It was a short and profane conversation, I said, ‘You’re doing a fucking show about Parkinson’s with Harrison fucking Ford, and you don’t call me?’”

Ford responded with laughter, and Fox recalled how Lawrence then said, “Well, I’m calling you now,” adding his own reply: “No, I’m calling you.”

Fox also commented on Lawrence’s influence in his career:

“a history of pulling me back out of retirement,”

recalling how they worked together on Scrubs after Fox initially retired from TV. He praised Lawrence as,

“a talented kid,”

noting the creator’s sustained ability to bring him back into significant roles despite their age difference.

Portraying Parkinson’s and Its Emotional Impact on Characters

Although Ford, now 83, is considerably older than Fox, both actors bring personal and professional insights to their portrayals of characters confronting Parkinson’s disease. In the show, Jerry tells Paul,

“We’re on the same shitty train to sucksville,”

capturing the shared struggle as they await treatment. The storyline later shows Paul regaining enthusiasm for his work by offering therapy to others living with Parkinson’s, including Jerry.

Fox highlighted the difficult relationship between psychological therapy and neurological illness:

“The thing about therapy is it’s a talking cure, but there’s no talking cure for Parkinson’s, so those two worlds have always had an uneasy relationship,”

he explained. He added,

“I couldn’t have gotten through Parkinson’s without therapy, but you find yourself educating the therapist as much as they’re educating you. You have to paint a picture of the ground you’re living on. And it’s very hard to explain to people.”

The Broader Importance of Their Work on Parkinson’s Awareness

The collaboration between Harrison Ford and Michael J. Fox in Shrinking brings heightened attention to Parkinson’s disease, combining Ford’s experience as an actor and patient with Fox’s decades of activism. Their public presence helps underscore the nuances of living with Parkinson’s, highlighting the need for continued research funding and improved therapies. Fox’s frustration at limited government support points to ongoing challenges in addressing neurodegenerative diseases comprehensively, while the series itself aims to humanize the disorder and its emotional toll.

As Fox meets with health officials and continues to fundraise, this joint spotlight by two prominent figures may influence policy makers and inspire broader conversations around brain health and care strategies in the United States.